# Human Rotavirus

## Rotarix 1.5mL/dose oral suspension

##### 

| TAH Drug Code      | LROT2                                                                                                                                                                                      |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Prevention of gastroenteritis caused by rotavirus, G1 & certain non-G1 serotypes.                                                                                                          |
| Dosing             | 1.5 mL, 2 doses administered orally starting at 6 weeks of age, the subsequent doses administered at intervals of at least 4 weeks. Th second dose should be given before 24 weeks of age. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                              |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                              |
| Contraindications  | Hypersensitivity, uncorrected congenital malformation of the GIT, known or suspected immunodeficiency.                                                                                     |
| Adverse Effects    | Irritability, loss of appetite, diarrhoea, vomiting, flatulence, abdominal pain, regurgitation of food, fever, fatigue.                                                                    |
| Pregnancy          | Unknown                                                                                                                                                                                    |
| Lactation          | Unknown                                                                                                                                                                                    |

## RotaTeq (MSD) 2mL/dose

##### 

| TAH Drug Code      | LROT3                                                                                                                                                                                  |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Prevention of rotavirus gastroenteritis in infant & children caused by the serotypes G1, G2, G3, G4 & G-serotypes that contain P1 (such as G9).                                        |
| Dosing             | 2 mL, 3 doses administered orally starting at 6-12 weeks of age, the subsequent doses administered at 4- to 10-weeks intervals. The third dose should be given before 32 weeks of age. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                          |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                          |
| Contraindications  | Hypersensitivity.                                                                                                                                                                      |
| Adverse Effects    | Diarrhea, vomiting, irritability, fever.                                                                                                                                               |
| Pregnancy          | Unknown                                                                                                                                                                                |
| Lactation          | Unknown                                                                                                                                                                                |

